BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28982901)

  • 1. Association Between Interleukin-10 Receptors and the CD45-Immunophenotype of Central Nervous System Tumors: A Preliminary Study.
    Zadka L; Kram P; Koscinski J; Jankowski R; Kaczmarek M; Piatek K; Kulus M; Gomułkiewicz A; Piotrowska A; Dziegiel P
    Anticancer Res; 2017 Oct; 37(10):5777-5783. PubMed ID: 28982901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas.
    Domingues PH; Teodósio C; Ortiz J; Sousa P; Otero A; Maillo A; Bárcena P; García-Macias MC; Lopes MC; de Oliveira C; Orfao A; Tabernero MD
    Am J Pathol; 2012 Nov; 181(5):1749-61. PubMed ID: 22982440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor infiltrating immune cells in gliomas and meningiomas.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar immunity profiles in patients with meningioma and glioma tumors despite differences in the apoptosis and necrosis of circulating lymphocyte and monocyte populations.
    Kataki A; Skandami V; Memos N; Nikolopoulou M; Oikonomou V; Androulis A; Konstadoulakis MM; Zografos CG
    J Neurosurg Sci; 2014 Mar; 58(1):9-15. PubMed ID: 24614787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
    Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors.
    Morantz RA; Wood GW; Foster M; Clark M; Gollahon K
    J Neurosurg; 1979 Mar; 50(3):305-11. PubMed ID: 422981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in meningiomas and gliomas.
    Georgakulias N; Singounas E; Kypriades E; Giotis J; Karvounis P
    Zentralbl Neurochir; 1993; 54(3):139-42. PubMed ID: 8237168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte subpopulations and their functional activity in patients with brain tumors].
    Rudenko VA; Lisianyĭ NI; Radzievskiĭ AA
    Vrach Delo; 1990 Sep; (9):91-4. PubMed ID: 2284786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative confocal microscopy for brain tumors: a feasibility analysis in humans.
    Sanai N; Eschbacher J; Hattendorf G; Coons SW; Preul MC; Smith KA; Nakaji P; Spetzler RF
    Neurosurgery; 2011 Jun; 68(2 Suppl Operative):282-90; discussion 290. PubMed ID: 21336204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
    Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
    Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
    Schröder R; Bien K; Kott R; Meyers I; Vössing R
    Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence automatic cell sorter and immunohistochemical investigation of CD68-positive cells in meningioma.
    Asai J; Suzuki R; Fujimoto T; Suzuki T; Nakagawa N; Nagashima G; Miyo T; Hokaku H; Takei A
    Clin Neurol Neurosurg; 1999 Dec; 101(4):229-34. PubMed ID: 10622450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two distinct primary brain tumors, in same region of the same patient: a case report.
    Tugcu B; Kepoglu U; Gunal M; Gunaldi O; Karakaya B; Demirgil BT
    J Neurooncol; 2006 Sep; 79(2):219-20. PubMed ID: 16557348
    [No Abstract]   [Full Text] [Related]  

  • 15. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
    Stevens A; Klöter I; Roggendorf W
    Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry in the diagnosis of brain tumors.
    Rabson AR
    Neurosurg Clin N Am; 1994 Jan; 5(1):135-46. PubMed ID: 8124088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on HLA-Dr expression of brain tumor cells and mononuclear cell subsets infiltrating in these tumors].
    Yu SZ; Xu XH; Zhang JQ
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug; 23(4):221-3. PubMed ID: 7805151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell infiltration of intrinsic and metastatic intracranial tumours.
    Strik HM; Stoll M; Meyermann R
    Anticancer Res; 2004; 24(1):37-42. PubMed ID: 15015573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
    Lisianyĭ NI; Markova OV; Zhmareva EN
    Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Local immune reactions of the cerebrospinal fluid in meningeal brain tumors].
    Khil'ko VA; Khlunovskiĭ AN; Starchenko AA; Komarets SA; Lushnov MS
    Zh Vopr Neirokhir Im N N Burdenko; 1995; (1):9-13. PubMed ID: 7762322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.